| |
|
|
| |
EVENT DETAILS |
Illumina Ventures is a life sciences venture capital fund with an emphasis on platform technologies & a partnership with Illumina. The $230M fund invests primarily in Series A tools, diagnostics, & therapeutics companies with a focus on early-stage, disruptive science & platforms. The investment team members have strong scientific & extensive entrepreneurial backgrounds & aim to add value for all of their portfolio companies. On Thursday April 24th 2018, Noel Lee & Wouter Meuleman, investment team members at Illumina Ventures, will give an overview presentation about the VC firm's key areas of interest. Following the presentation, you'll have the opportunity to introduce yourself to Wouter & Noel during the networking lunch. And finally, for those companies who apply online & are approved, one-on-one meetings with Illumina Ventures provides an intimate forum to discuss your company. Areas of Interest include:
Therapeutics companies & discovery platforms (oncology, infectious disease, etc.)
Life science platforms
Research tools
Reproductive Health
Agrigenomics
Complex Diseases
Microbiome
Informatics, AI, & Genomics Analysis
For more information, visit http://www.illuminaventures.com. Agenda: 10:30 AM | Registration & Networking 11:00 AM | Presentation & Q&A 11:45 AM | Networking & Lunch 1:00 PM - 5:00 PM | One-on-one Meetings* *Companies must have applied for a one-on-one meeting ahead of time & be approved. The application period ends on April 3rd, 2018. Fees: Presentation & Lunch $25 | General Public $35 | General Public Onsite Includes presentation, Q&A, & lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, & lunch will remain open until noon on April 24th (or sold out). One-on-One Meeting FREE | Application FREE | Accepted Companies Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on April 3rd. Your application will be reviewed & you will be notified of acceptance by April 18. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved. Location: New York Genome Center 101 6th Ave New York, New York 10280 About the Meet with... Series: The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals & clarify what types of products or research they are interested in & how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, & OrbiMed. Illumina Ventures Participating Representatives: Wouter Meuleman PhD | Director of Investments Wouter is Director of Investments at San Francisco-based Illumina Ventures. Prior to Illumina Ventures, Wouter worked at Illumina in various roles throughout the organization including R&D, Product Development, & Corporate Development. A physical chemist by training, he began his career in life sciences as first hire for Oxford University spin-out Oxamer, a company founded in 2003 by Prof. Sir Edwin Southern, where he led the development a benchtop DNA microarray fabrication platform. Following the company's incorporation into Oxford Gene Technology in 2005, he continued working alongside Prof. Southern leading R&D programs in areas such as single cell gene expression analysis & novel applications for DNA microarrays. He obtained his undergraduate & Master's degree in Chemistry from the University of Ghent, Belgium; a PhD in Chemical Engineering from the University of Newcastle, U.K; & an MBA from the University of Cambridge, U.K. Connect with Wouter: Noel Jee PhD | Investment Associate Noel is an Investment Associate at Illumina Ventures, where he focuses on investments in life science tools & therapeutics. Prior to joining the fund, Noel worked at L.E.K. Consulting as a management consultant specializing in the life sciences. He has consulted on strategy engagements for companies in the pharmaceuticals, biotech, & diagnostics industries. Before joining L.E.K. Consulting, Noel helped to co-found & bootstrap the San Francisco-based medical device & digital health startup Knox Medical Diagnostics, where he led the initial business development. He obtained dual BS degrees from the University of Maryland College Park, & his PhD in Chemistry & Chemical Biology from the University of California San Francisco. Connect with Noel:
|
|
|
|
|
|
